Download | < Back |
02 May 2016 | |
Marksans Pharma Ltd has informed BSE regarding a Press Release dated May 02, 2016, titled "Marksans Pharma Limited announces USFDA approval for Metformin Hydrochloride Extended-Release (ER) Tablets USP 500mg and 750mg (ANDA 090295)". | |
View all announcements for MARKSANS PHARMA LTD. | Source: BSE India |